Optimal PEGylation can Improve the Exposure of Interferon in the Lungs Following Pulmonary Administration. Issue 4 (28th January 2015)
- Record Type:
- Journal Article
- Title:
- Optimal PEGylation can Improve the Exposure of Interferon in the Lungs Following Pulmonary Administration. Issue 4 (28th January 2015)
- Main Title:
- Optimal PEGylation can Improve the Exposure of Interferon in the Lungs Following Pulmonary Administration
- Authors:
- Mcleod, Victoria M.
Chan, Linda J.
Ryan, Gemma M.
Porter, Christopher J. H.
Kaminskas, Lisa M. - Abstract:
- <abstract abstract-type="main" xml:lang="en"> <title> <x xml:space="preserve">Abstract</x> </title> <p>The utility of inhaled protein therapeutics to treat lung‐resident diseases is limited by protein degradation in the lungs and rapid clearance. This study therefore aimed to evaluate the impact of PEGylation on the lung and systemic exposure of interferon (IFN) α2 after intratracheal administration to rats. An inverse correlation was observed between PEG chain length and systemic exposure, where bioavailability was 5.5% for the 31 kDa PEGylated construct and &lt;0.4% for the 60 kDa PEGylated construct when compared with 15% for native IFN (19 kDa). Retention of PEGylated IFNα within the lungs increased 2.5‐fold to threefold when compared with native IFN. When comparing the lung and systemic exposure of PEGylated and native IFN in terms of protein biological activity, the 31 kDa PEGylated construct increased exposure by 50% and 100%, respectively, when compared with native IFN, but the 60 kDa PEG construct offered no benefit. Preliminary work also indicated that the conjugation of IFNγ with 10 kDa PEG significantly increases the retention of the protein within the lung. Optimal PEGylation may therefore be used as a means to improve the exposure of lung‐resident diseases to therapeutic cytokines and potentially reduce systemic exposure and side effects as well as dosing frequency. © 2015 Wiley Periodicals, Inc. and the American Pharmacists Association J Pharm Sci<abstract abstract-type="main" xml:lang="en"> <title> <x xml:space="preserve">Abstract</x> </title> <p>The utility of inhaled protein therapeutics to treat lung‐resident diseases is limited by protein degradation in the lungs and rapid clearance. This study therefore aimed to evaluate the impact of PEGylation on the lung and systemic exposure of interferon (IFN) α2 after intratracheal administration to rats. An inverse correlation was observed between PEG chain length and systemic exposure, where bioavailability was 5.5% for the 31 kDa PEGylated construct and &lt;0.4% for the 60 kDa PEGylated construct when compared with 15% for native IFN (19 kDa). Retention of PEGylated IFNα within the lungs increased 2.5‐fold to threefold when compared with native IFN. When comparing the lung and systemic exposure of PEGylated and native IFN in terms of protein biological activity, the 31 kDa PEGylated construct increased exposure by 50% and 100%, respectively, when compared with native IFN, but the 60 kDa PEG construct offered no benefit. Preliminary work also indicated that the conjugation of IFNγ with 10 kDa PEG significantly increases the retention of the protein within the lung. Optimal PEGylation may therefore be used as a means to improve the exposure of lung‐resident diseases to therapeutic cytokines and potentially reduce systemic exposure and side effects as well as dosing frequency. © 2015 Wiley Periodicals, Inc. and the American Pharmacists Association J Pharm Sci 104:1421–1430, 2015</p> </abstract> … (more)
- Is Part Of:
- Journal of pharmaceutical sciences. Volume 104:Issue 4(2015:Apr.)
- Journal:
- Journal of pharmaceutical sciences
- Issue:
- Volume 104:Issue 4(2015:Apr.)
- Issue Display:
- Volume 104, Issue 4 (2015)
- Year:
- 2015
- Volume:
- 104
- Issue:
- 4
- Issue Sort Value:
- 2015-0104-0004-0000
- Page Start:
- 1421
- Page End:
- 1430
- Publication Date:
- 2015-01-28
- Subjects:
- Pharmacy -- Periodicals
615.1 - Journal URLs:
- http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1520-6017 ↗
http://www.jpharmsci.org/issues ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1002/jps.24353 ↗
- Languages:
- English
- ISSNs:
- 0022-3549
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 5031.900000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 4340.xml